Objectives: Bone morphogenetic protein-8B (BMP8B) is an adipokine that is synthesized in many tissues and has been shown to be associated with the development of obesity and metabolic disorders in animals and humans. The aim of this study is to investigate the relationship between serum BMP8B levels and various metabolic parameters in women with PCOS. Material and methods: This cross-sectional study included 80 women with PCOS and 40 age- and BMI-matched controls without PCOS. BMP8B, total cholesterol, triglyceride,fasting blood glucose (FBG), insulin, total testosterone (T),follicle stimulating hormone (FSH), luteinizing hormone (LH),estradiol (E2) levels were measured in all the participants. HOMA-IR was used to calculate the insulin resistance. Results: Serum BMP8B levels were lower in women with PCOS than in healthy women(43.11±13.09 [ng/mL]vs. 106.45±52.32 [ng/mL], p< 0.001). HOMA-IR, LH/FSH, total-testosterone, total cholesterol, and triglyceride levels were significantly higher in women with PCOS than controls. Circulating BMP8B levels were positively correlated with HOMA-IR,BMI in PCOS group; was positively correlated with triglyceride in Control group. Conclusion: The low concentration of circulating BMP8B in PCOS may be associated with insulin resistance,Lipid metabolism and BMI,bat may be a new target for PCOS treatment.

The authors have declared no competing interest.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ethics Committee of the Affiliated Hospital of Hebei University

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes